Compare ARPA (ARPA) vs Mira (MIRA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARPA vs Mira — how do they compare? ARPA trades at Rp150.35 (market cap Rp228,53M, Rp94,65M 24h volume), while Mira trades at Rp696.68 (market cap Rp224,75M, Rp102,62M 24h volume). The key difference: ARPA and Mira are close in size by market cap, and Mira's supply is capped (321,5M / 1B MIRA (33%)) while ARPA's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold ARPA for 42 Days and Mira for 22 Days on average.
| ARPA | MIRA | |
|---|---|---|
Market Cap | Rp228,53M | Rp224,75M |
Volume (24h) | Rp94,65M | Rp102,62M |
Circulating Supply | 1,5B ARPA | 321,5M / 1B MIRA (33%) |
Typical Hold Time | 42 Days | 22 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARPA is trading at Rp151.96 with a bearish technical signal, currently near the pivot point of Rp152. Support levels are at Rp149, Rp146, and Rp143, while resistance lies at Rp155, Rp158, and Rp161. The market cap is Rp230.77 million with a hold time of 42 days, indicating moderate holding behavior. No major protocol updates or ecosystem news are available, keeping fundamental developments neutral.
Overall outlook is cautious due to bearish technicals and limited fundamental catalysts. Opportunities include potential rebounds from support zones, but risks involve low liquidity and high volatility. Investors should monitor for any network updates or exchange developments that could impact price action.
MIRA token trades at Rp724 with bearish technical signals as moving averages indicate strong selling pressure. The token shows neutral oscillators but faces resistance at Rp726-758 levels. With 33% circulating supply and 22-day average hold time, market participation remains limited. Recent ecosystem developments show progress in pharmaceutical research applications, though direct token utility updates are scarce.
Overall outlook remains cautious due to technical bearishness and limited trading volume. Key opportunity lies in potential protocol adoption from pharmaceutical research partnerships. Major risks include low liquidity, high volatility, and regulatory uncertainty surrounding crypto-pharma intersections. Investors should monitor exchange listings and token utility expansion.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About ARPA
ARPA Network (ARPA) is a decentralized secure computation network built to improve the fairness, security, and privacy of blockchains. ARPA threshold BLS signature network serves as the infrastructure of verifiable Random Number Generator (RNG), secure wallet, cross-chain bridge and decentralized custody across multiple blockchains. ARPA was previously known as ARPA Chain, a privacy-preserving Multi-party Computation (MPC) network founded in 2018. ARPA Mainnet has completed over 224,000 computation tasks in the past years.
Read more on ARPA →About Mira
Mira is a decentralized verification network that enables autonomous AI by eliminating human oversight. Using consensus-based verification across multiple AI models, Mira delivers mathematically verifiable and trustless results in real time. This ensures accuracy and reliability for critical fields like healthcare, finance, and law—transforming AI from a supervised tool into truly independent intelligence.
Read more on MIRA →
